| 11 | Radioisotopes (Radionuclides)IBA
04/2021
-
12/2012 |
| 5 | Folic Acid (Vitamin M)FDA LinkGeneric
08/2019
-
12/2012 |
| 4 | TerbiumIBA
01/2022
-
12/2012 |
| 3 | Terbium-161IBA
01/2022
-
10/2014 |
| 3 | Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
01/2022
-
05/2014 |
| 3 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2022
-
12/2012 |
| 3 | AntigensIBA
11/2019
-
07/2019 |
| 2 | Peptides (Polypeptides)IBA
01/2022
-
12/2016 |
| 2 | Edotreotide (SMT 487)IBA
01/2022
-
04/2021 |
| 2 | Somatostatin Receptors (Somatostatin Receptor)IBA
01/2022
-
12/2016 |
| 2 | IsotopesIBA
04/2021
-
01/2020 |
| 1 | LutetiumIBA
04/2021 |
| 1 | Erbium-169IBA
01/2021 |
| 1 | polyethylene glycol polyethyleneimine nanogelIBA
01/2021 |
| 1 | Boron CompoundsIBA
09/2020 |
| 1 | BoronIBA
09/2020 |
| 1 | Silver-111IBA
08/2020 |
| 1 | Coloring Agents (Dyes)IBA
01/2020 |
| 1 | AstatineIBA
01/2020 |
| 1 | 2,3,5,6-tetrafluoro-4-sulfanylbenzoic acidIBA
01/2020 |
| 1 | azaBDPBA compoundIBA
01/2020 |
| 1 | 4,4- difluoro- 4- bora- 3a,4a- diaza- s- indacene (BODIPY)IBA
01/2020 |
| 1 | SodiumIBA
01/2020 |
| 1 | 177Lu-PSMA-617IBA
08/2019 |
| 1 | gallium 68 PSMA-11IBA
07/2019 |
| 1 | PSMA-617IBA
07/2019 |
| 1 | Pentetic Acid (DTPA)FDA LinkGeneric
06/2019 |
| 1 | RadiopharmaceuticalsIBA
01/2019 |
| 1 | Lanthanoid Series Elements (Lanthanides)IBA
01/2019 |
| 1 | Lutetium-177IBA
10/2014 |
| 1 | Monoclonal AntibodiesIBA
10/2014 |
| 1 | Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
10/2014 |
| 1 | Terbium-155IBA
05/2014 |
| 1 | Biological ProductsIBA
05/2014 |
| 1 | Cholecystokinin B ReceptorIBA
05/2014 |
| 1 | minigastrinIBA
05/2014 |